Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126806852 | 12680685 | 2 | F | 200912 | 20160802 | 20160824 | 20160921 | EXP | CN-BAYER-2016-160594 | BAYER | 32.00 | YR | A | M | Y | 0.00000 | 20160921 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126806852 | 12680685 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, BID | D | 21923 | 400 | MG | FILM-COATED TABLET | BID | |||||
| 126806852 | 12680685 | 2 | C | ENTECAVIR. | ENTECAVIR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126806852 | 12680685 | 1 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126806852 | 12680685 | DE |
| 126806852 | 12680685 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126806852 | 12680685 | Alopecia | |
| 126806852 | 12680685 | Gingival swelling | |
| 126806852 | 12680685 | Hepatocellular carcinoma | |
| 126806852 | 12680685 | Palmar-plantar erythrodysaesthesia syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126806852 | 12680685 | 1 | 200912 | 0 |